| Effects of lead and cadmium on the immune system and cancer progression M Ebrahimi, N Khalili, S Razi, M Keshavarz-Fathi, N Khalili, N Rezaei Journal of Environmental Health Science and Engineering 18, 335-343, 2020 | 145 | 2020 |
| IL-17 and colorectal cancer: From carcinogenesis to treatment S Razi, BB Noveiry, M Keshavarz-Fathi, N Rezaei Cytokine 116, 7-12, 2019 | 108 | 2019 |
| Current and future perspectives of PD-1/PDL-1 blockade in cancer immunotherapy R Makuku, N Khalili, S Razi, M Keshavarz-Fathi, N Rezaei Journal of immunology research 2021, 1-15, 2021 | 100 | 2021 |
| A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications SS Sedighzadeh, AP Khoshbin, S Razi, M Keshavarz-Fathi, N Rezaei Translational lung cancer research 10 (4), 1889, 2021 | 93 | 2021 |
| Importance of TNF-alpha and its alterations in the development of cancers PM Sharif, P Jabbari, S Razi, M Keshavarz-Fathi, N Rezaei Cytokine 130, 155066, 2020 | 64 | 2020 |
| Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site E Nasrollahzadeh, S Razi, M Keshavarz-Fathi, M Mazzone, N Rezaei Cancer Immunology, Immunotherapy 69 (9), 1673-1697, 2020 | 46 | 2020 |
| An overview of the role of interleukin-8 in colorectal cancer S Najdaghi, S Razi, N Rezaei Cytokine 135, 155205, 2020 | 39 | 2020 |
| Cancer-associated fibroblasts in colorectal cancer S Kamali Zonouzi, PS Pezeshki, S Razi, N Rezaei Clinical and Translational Oncology, 1-13, 2022 | 37 | 2022 |
| The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers M Gouravani, N Khalili, S Razi, M Keshavarz-Fathi, N Khalili, N Rezaei Expert Review of Clinical Immunology 16 (2), 175-187, 2020 | 24 | 2020 |
| DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner S Razi, A Sadeghi, Z Asadi-Lari, KJ Tam, E Kalantari, Z Madjd Clinical and Experimental Medicine 21, 139-147, 2021 | 17 | 2021 |
| Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness F Darbeheshti, S Kadkhoda, M Keshavarz-Fathi, S Razi, A Bahramy, ... BMC cancer 22 (1), 668, 2022 | 10 | 2022 |
| TGF-β signaling and the interaction between platelets and T-cells in tumor microenvironment: Foes or friends? AS Razavi, M Mohtashami, S Razi, N Rezaei Cytokine 150, 155772, 2022 | 9 | 2022 |
| The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies F Sheida, S Razi, M Keshavarz-Fathi, N Rezaei Expert Review of Anticancer Therapy 22 (1), 65-81, 2022 | 8 | 2022 |
| Advances in pharmacotherapy for neuroblastoma PS Pezeshki, A Moeinafshar, F Ghaemdoust, S Razi, M Keshavarz-Fathi, ... Expert Opinion on Pharmacotherapy 22 (17), 2383-2404, 2021 | 8 | 2021 |
| Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article R Makuku, H Seyedmirzaei, MM Tantuoyir, E Rodríguez-Román, ... International Immunopharmacology 105, 108580, 2022 | 7 | 2022 |
| Targeting ferroptosis as a cell death pathway in Melanoma: From molecular mechanisms to skin cancer treatment GM Tavakoli, MH Mirzapour, S Razi, N Rezaei International Immunopharmacology 119, 110215, 2023 | 6 | 2023 |
| The role of dendritic cells in neuroblastoma: Implications for immunotherapy R Zafari, S Razi, N Rezaei Immunobiology 227 (6), 152293, 2022 | 6 | 2022 |
| AMPK’s double-faced role in advanced stages of prostate cancer F Gharibpoor, S Kamali Zonouzi, S Razi, N Rezaei Clinical and Translational Oncology 24 (11), 2064-2073, 2022 | 6 | 2022 |
| Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2) H Seyedmirzaei, M Keshavarz-Fathi, S Razi, M Gity, N Rezaei Journal of Oncology Pharmacy Practice 27 (5), 1235-1244, 2021 | 6 | 2021 |
| The signaling and the metabolic differences of various CAR T cell designs AS Razavi, A Loskog, S Razi, N Rezaei International Immunopharmacology 114, 109593, 2023 | 5 | 2023 |
Nima RezaeiTehran University of Medical Sciences; Universal Scientific Education and Research Network (USERN)Verified email at tums.ac.ir
